Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

Blood Cancer Journal, Published online: 08 June 2020; doi:10.1038/s41408-020-0333-2Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

Source: Blood Cancer Journal - June 7, 2020 Category: Hematology Authors: Giovanni Caocci Olga Mulas Isabella Capodanno Elisabetta Abruzzese Alessandra Iurlo Luigiana Luciano Francesco Albano Mario Annunziata Mario Tiribelli Massimiliano Bonifacio Sara Galimberti Fausto Castagnetti Nicola Sgherza Fabio Stagno Antonella Gozzini Source Type: research